United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
-5.57%
2025 (actual)
ROA
-2.62%
2025 (actual)
Gross Margin
100%
2025 (actual)
Net Margin
-7.06%
2025 (actual)
Total Assets
$14,022.00M
2025 (actual)
Net Income
-$360.00M
2025 (actual)
Valuation
$6,100.38M
2026 (forecast)
Stock Price
$17.08
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
+113.4 pt
Company
Sector average
ROA
-184.6 pt
Company
Gross Margin
+0 pt
Company
Sector average
Net Margin
-432.1 pt
Company
Total Assets
+54.1%
Company
Sector average
Net Income
-10,789.5%
Company
Valuation
+546.9%
Company
Sector average (own scale)
Stock Price
+546.9%
Company
Sector average (own scale)
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for Bausch & Lomb Corp? It covers the balance sheet, income statement, cash flow and Equlion model projections.